A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford progeria syndrome mutation

Hutchinson-Gilford progeria syndrome (HGPS) is caused by the production of a truncated prelamin A, called progerin, which is farnesylated at its carboxyl terminus. Progerin is targeted to the nuclear envelope and causes misshapen nuclei. Protein farnesyltransferase inhibitors (FTI) mislocalize proge...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Yang, Shao H., Meta, Margarita, Qiao, Xin, Frost, David, Bauch, Joy, Coffinier, Catherine, Majumdar, Sharmila, Bergo, Martin O., Young, Stephen G., Fong, Loren G.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2006
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1513052/
https://ncbi.nlm.nih.gov/pubmed/16862216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI28968
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados